RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.

NCT05127798 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia, Adult

Interventions

OTHER: Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.

Sponsor

Grupo Argentino de Tratamiento de la Leucemia Aguda